1) portal vein stenosis
门静脉缩窄
2) Portal vein
门静脉
1.
Double chemoembolization of hepatic carcinoma by TACE and portal vein PCS:evaluation of MSCT volumetric measurement;
26例原发性肝癌经肝动脉和门静脉双重介入治疗的多层螺旋CT体积测量评价
2.
Effect of percutaneous chemotherapy pump placement for portal vein chemotherapy on hepatic metastasis of colorectal cancer;
经皮化疗泵植入门静脉化疗治疗结直肠癌肝转移的临床观察
3.
Evaluation of MSCT volumetric measurement of double chemoembolization of hepatic carcinoma by TACE and portal vein port catheter system;
原发性肝癌经TACE联合门静脉PCS双重治疗的MSCT评价
3) Portal
门静脉
1.
Oral Contraceptive-induced Portal Vein Cavernous Transformation with Multiple Thrombosis:A Case Report;
口服避孕药致门静脉海绵样变性伴多发性血栓1例
2.
Effects of low dose of losartan on rats with portal hypertension;
小剂量氯沙坦治疗大鼠肝硬化门静脉高压症的实验研究
3.
Role of vascular endothelial growth factor and its receptor mRNA in portal hypertensive gastropathy;
VEGF及其受体在门静脉高压性胃病中的作用
4) hepatic portal vein
肝门静脉
1.
Three dimensional reconstruction and real time display of hepatic portal vein of first Chinese digitized visible human;
首例中国数字化可视人体肝门静脉系的三维重建与实时显示
2.
The morphological observation of embranchment of the hepatic portal vein within liver;
肝门静脉肝内分支的形态观测及临床意义
3.
Comparison of microstructural component between human and pig hepatic portal vein;
人与猪肝门静脉显微结构成分的比较
5) Portal vein lump
门静脉瘤
6) portal vein blood
门静脉血
1.
Clinical significance of the expression of CK20 mRNA in portal vein blood of patients with colorectal cancer during operation;
大肠癌术中门静脉血CK20 mRNA检测临床意义的探讨
2.
Methods:CK20 mRNA was detected in Portal vein blood samples of patients with rectal cancer before and after operation from 50 patients by reverse transcription polymerase chain reaction (RT-PCR).
目的 :研究直肠癌门静脉血 CK2 0 m RNA表达及临床意义。
参考词条
补充资料：垂体门静脉系统
垂体门静脉系统
是下丘脑和垂体前叶间的一个特殊的血液循环体系。垂体上动脉在正中隆起处首先形成丰富的毛细血管丛，是为门静脉前毛细血管丛，此丛汇集成若干条静脉于，即垂体门静脉。它们沿垂体柄下行进入垂体前叶，再次分支形成毛细血管丛，是为门静脉后毛细血管丛。这种特殊的血管构筑称为"垂体门静脉系统"。该系与腺垂体分泌的调节有密切关联。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。